These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22438730)

  • 1. Protein reporter bioassay systems for the phenotypic screening of candidate drugs: a mouse platform for anti-aging drug screening.
    Chiba T; Tsuchiya T; Mori R; Shimokawa I
    Sensors (Basel); 2012; 12(2):1648-56. PubMed ID: 22438730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery Channel: microfluidics and microengineered systems in drug screening.
    Moraes C
    Integr Biol (Camb); 2015 Mar; 7(3):285-8. PubMed ID: 25677245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting high-throughput screening methods and assays for biocontainment laboratories.
    Rasmussen L; Tigabu B; White EL; Bostwick R; Tower N; Bukreyev A; Rockx B; LeDuc JW; Noah JW
    Assay Drug Dev Technol; 2015; 13(1):44-54. PubMed ID: 25710545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous Locus Reporter Assays.
    Liu Y; Hermes J; Li J; Tudor M
    Methods Mol Biol; 2018; 1755():163-177. PubMed ID: 29671270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput screening normalized to biological response: application to antiviral drug discovery.
    Patel DA; Patel AC; Nolan WC; Huang G; Romero AG; Charlton N; Agapov E; Zhang Y; Holtzman MJ
    J Biomol Screen; 2014 Jan; 19(1):119-30. PubMed ID: 23860224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic in vivo screen identifies compounds enhancing neuronal regeneration.
    Rohde CB; Gilleland C; Samara C; Norton S; Haggarty S; Yanik MF
    Annu Int Conf IEEE Eng Med Biol Soc; 2009; 2009():5950-2. PubMed ID: 19965065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miniaturized microfluidic formats for cell-based high-throughput screening.
    Upadhaya S; Selvaganapathy PR
    Crit Rev Biomed Eng; 2009; 37(3):193-257. PubMed ID: 20402621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs.
    Singh SS
    Curr Drug Metab; 2006 Feb; 7(2):165-82. PubMed ID: 16472106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.
    White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS
    Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based screening using high-throughput flow cytometry.
    Black CB; Duensing TD; Trinkle LS; Dunlay RT
    Assay Drug Dev Technol; 2011 Feb; 9(1):13-20. PubMed ID: 21050072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in laser scanning imaging cytometry for high-content screening.
    Wylie PG; Onley DJ; Hammerstein AF; Bowen WP
    Assay Drug Dev Technol; 2015 Mar; 13(2):66-78. PubMed ID: 25654565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Back to the future with phenotypic screening.
    Prior M; Chiruta C; Currais A; Goldberg J; Ramsey J; Dargusch R; Maher PA; Schubert D
    ACS Chem Neurosci; 2014 Jul; 5(7):503-13. PubMed ID: 24902068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discovery.
    Patel DA; Patel AC; Nolan WC; Zhang Y; Holtzman MJ
    PLoS One; 2012; 7(5):e36594. PubMed ID: 22574190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of semiautomated 96-well transport assay using LLC-PK1 cells transfected with human P-glycoprotein for high-throughput screening.
    Miyamoto R; Nozawa T; Kimura M; Shiozuka K; Tabata K
    Assay Drug Dev Technol; 2015 Mar; 13(2):79-87. PubMed ID: 25785771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High impact technologies for natural products screening.
    Koehn FE
    Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Image-based chemical screening.
    Carpenter AE
    Nat Chem Biol; 2007 Aug; 3(8):461-5. PubMed ID: 17637778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-Based Assay Design for High-Content Screening of Drug Candidates.
    Nierode G; Kwon PS; Dordick JS; Kwon SJ
    J Microbiol Biotechnol; 2016 Feb; 26(2):213-25. PubMed ID: 26428732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BioAssay ontology annotations facilitate cross-analysis of diverse high-throughput screening data sets.
    Schürer SC; Vempati U; Smith R; Southern M; Lemmon V
    J Biomol Screen; 2011 Apr; 16(4):415-26. PubMed ID: 21471461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.